Cytokine and cytokine receptor polymorphisms in infectious disease

Intensive Care Medicine, Supplement

Volumn 26, Issue 1, 2000, Pages

  Van Deventer, S J H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Crohn's disease; Interleukin 10; Intestinal mucosa; T lymphocytes; Tumor necrosis factor

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; LIPOPROTEIN; TUMOR NECROSIS FACTOR;

CONFERENCE PAPER; CYTOKINE PRODUCTION; GENE MUTATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GRAM NEGATIVE BACTERIUM; HUMAN; INFECTION; LIPOPROTEIN BLOOD LEVEL; SEPSIS;

ANIMALS; BACTERIAL INFECTIONS; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; MUTATION; POLYMORPHISM, GENETIC; RECEPTORS, CYTOKINE; SEPSIS;

EID: 0034026082     PISSN: 09351701     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Hill AV (1998) The immunogenetics of human infectious diseases. Annu Rev Immunol 16: 593-617
2. Van Deventer SJH, Buller HR, Ten Cate JW, Sturk A, Pauw W (1988) Endotoxaemia: an early predictor of septicaemia in febrile patients. Lancet 1: 605-609
3. Tobias PS, Soldau K, lovine NM, Elsbach P, Weiss J (1997) Lipopolysaccharide (LPS)-binding proteins BPI and LBP form different types of complexes with LPS. J Biol Chem 272: 18682-18685
4. Tapping RI, Gegner JA, Kravchenko VV, Tobias PS (1998) Roles for LBP and soluble CD14 in cellular uptake of LPS. Prog Clin Biol Res 397: 73-78
5. Han J, Bohuslav J, Jiang Y (1998) CD14 dependent mechanisms of cell activation. Prog Clin Biol Res 397: 157-168
6. Schimke J, Mathison J, Morgiewicz J, Ulevitch RJ (1998) Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin. Proc Natl Acad Sci U S A 95: 13875-13880
7. Leturcq DJ, Moriarty AM, Talbott G, Winn RK, Martin TR, Ulevitch RJ (1996) Antibodies against CD14 protect primates from endotoxin-induced shock. J Clin Invest 98: 1533-1538
8. Tapping RI, Tobias PS (1997) Cellular binding of soluble CD14 requires lipopolysaccharide (LPS) and LPS-binding protein. J Biol Chem 272: 23157-23164
9. Ulevitch RJ (1999) Endotoxin opens the Tollgates to innate immunity [news]. Nat Med 5: 144-145
10. Poltorak A, Smirnova I, He X (1998) Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Molecules Diseases 24: 340-355
11. Adachi O, Kawai T, Takeda K (1998) Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143-150
12. Medzhitov R, Preston-Hurlburt P, Kopp E (1998) MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Molec Cell 2: 253-258
13. Kanakaraj P, Schafer PH, Cavender DE (1998) Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production. J Exp Med 187: 2073-2079
14. O'Neill LA, Greene C (1998) Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol 63: 650-657
15. Poltorak A, He X, Smirnova I (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088
16. Schumann RR, Kirschning CJ, Unbehaun A (1996) The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/ 3 and other cytokine-inducible nuclear proteins. Molec Cell Biol 16: 3490-3503
17. Pajkrt D, Doran JE, Koster F (1996) Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J Exp Med 184: 1601-1608
18. Jongeneel CV, Briant L, Udalova IA, Sevin A, Nedospasov SA, Cambon-Thomsen A (1991) Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. Proc Natl Acad Sci U S A 88: 9717-9721
19. Jongeneel CV (1995) Transcriptional regulation of the tumor necrosis factor alpha gene. Immunobiology 193: 210-216
20. Stuber F, Petersen M, Bokelmann F, Schade U (1996) A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis [see comments]. Crit Care Med 24: 381-384
21. Stuber F, Udalova IA, Book M, et al (1995) -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter [see comments]. J Inflamm 46: 42-50
22. Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verweij CL (1995) Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation [see comments]. J Inflamm 46: 32-41
23. Kaijzel EL, van Krugten MV, Brinkman BM, et al (1998) Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis. Molec Med 4: 724-733
24. McDermott MF, Aksentijevich I, Galon J, et al (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97: 133-144
25. Stokkers PCF, Vanaken BE, Basoski N, Reitsma PH, Tytgat GNJ, Vandeventer SJH (1998) Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease. Gut 43: 33-39
26. Wilkinson RJ, Patel P, Llewelyn M, et al (1999) Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1 beta on tuberculosis. J Exp Med 189: 1863-1874
27. Lu B, Ebensperger C, Dembic Z, et al (1998) Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in mice. Proc Natl Acad Sci U S A 95: 8233-8238
28. de Jong R, Altare F, Haagen IA, et al (1998) Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280: 1435-1438
29. Altare F, Durandy A, Lammas D, et al (1998) Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280: 1432-1435
30. Newport MJ, Huxley CM, Huston S, et al (1996) A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 335: 1941-1949
31. Jouanguy E, Altare F, Lamhamedi S, et al (1996) Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med 335: 1956-1961